ASTRAZENECA PLC (AZN)
Clinical trial NCT07218172 updates: 1. status: COMPLETED → ACTIVE_NOT_RECRUITING 2. completion date: 2025-04-24 → 2026-11-30 3. primary completion date: 2025-04-24 → 2026-11-30 4. enrollment type: ACTUAL → ESTIMATED
Clinical trial NCT07218172 updates: 1. status: COMPLETED → ACTIVE_NOT_RECRUITING 2. completion date: 2025-04-24 → 2026-11-30 3. primary completion date: 2025-04-24 → 2026-11-30 4. enrollment type: ACTUAL → ESTIMATED
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical